AKT1 and ovarian cancer: Together, these results indicate that GSK690693 blocked the miR-29b silencing-induced glycolytic metabolic changes and thus provide additional evidence of the function of the miR-29b-AKT axis in regulating the Warburg effect in ovarian cancer cells.